Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55,574,229
-
Total 13F shares
-
10,090,990
-
Share change
-
+200,578
-
Total reported value
-
$184,865,000
-
Price per share
-
$18.32
-
Number of holders
-
24
-
Value change
-
+$3,824,983
-
Number of buys
-
9
-
Number of sells
-
10
Institutional Holders of Ascendis Pharma A/S - ADR (ASND) as of Q4 2015
As of 31 Dec 2015,
Ascendis Pharma A/S - ADR (ASND) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,090,990 shares.
The largest 10 holders included
FMR LLC, RA CAPITAL MANAGEMENT, LLC, Visium Asset Management, LP, RS INVESTMENT MANAGEMENT CO LLC, VHCP Management II, LLC, JANUS CAPITAL MANAGEMENT LLC, ACUTA CAPITAL PARTNERS, LLC, BAKER BROS. ADVISORS LP, Sio Capital Management, LLC, and Rock Springs Capital Management LP.
This page lists
24
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.